Embed Size (px)
Citation preview
1
Clinical Trial Management Systems (CTMS)Market, by Components, (Software,
Service), Delivery Mode (Web-based, On-site, Cloud-based) End-users
(Pharmaceutical and BiotechnologyCompanies, Contract ResearchOrganizations, Medical Device
Companies), – Global Revenue, Trends,Growth, Share, Size and
Forecast to 2022
December 2016
2
About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S. based market research and
consulting firm that serves Fortune 1000 companies, leading businesses, and
upcoming organizations from around the world to help them achieve their business
goal of sustainable revenue growth, utilizing Scalar's premium market research
reports and consulting services to make critical strategic decisions.
Our real-time industry data tracking, with the help of advanced analytics and
machine learning, offers our clients highly accurate 360-degree perspective of key
developments in niche markets. Our team of industry experts, with a thorough
understanding of global markets and cumulative industry experience spanning 100+
years, work relentlessly to help our clients realize their most important business
goals.
Terms of Use
This report bears a contractual agreement between Scalar Market Research and the
buyer. No part of the content of this report can be shared or published to other
individuals, companies, subsidiaries, divisions, or subdivisions of any organization.
The redistribution of the report in any manner is strictly prohibited without the prior
permission of Scalar Market Research. The publisher will, in turn, regard the privacy
of the purchaser, and will keep it confidential. This report is informative material and
is not meant for managerial, legal or accounting advice. This publication in no case
should be used as an endorsement of any product, a corporate guide or, business
manual.
Copyright © 2016 Scalar Market Research, Inc., USA
All Rights Reserved. This document enclosing highly confidential information is the sole
property of Scalar Market Research. No part of this document shall be reproduced, copied,
quoted, circulated, or otherwise shared without prior approval of Scalar Market Research.
SAMPLE
3
Table of Contents
1 MARKET OVERVIEW......................................................................................................................16
1.1 Definitions.............................................................................................................................16
1.2 Research Methodology .........................................................................................................16
1.2.1 Primary Data .................................................................................................................17
1.2.2 Secondary Data .............................................................................................................17
1.2.3 Machine Learning..........................................................................................................18
1.2.4 Research Scope .............................................................................................................18
1.2.5 Years Considered ..........................................................................................................20
1.2.6 Currency & Pricing.........................................................................................................21
1.3 Market Segmentation ...........................................................................................................21
1.4 Key Objectives & Benefits of the Report...............................................................................23
1.4.1 Objectives of the Report ...............................................................................................23
1.4.2 Key Benefits of the Report ............................................................................................23
2 EXECUTIVE SUMMARY ..................................................................................................................24
3 MARKET DYNAMICS ......................................................................................................................26
3.1 Drivers ...................................................................................................................................26
3.2 Restraints ..............................................................................................................................27
3.3 Opportunities........................................................................................................................28
3.3.1 Increasing global geriatric population ..........................................................................28
3.3.2 High prevalence rate of chronic diseases .....................................................................28
3.3.3 Increased Healthcare Awareness..................................................................................29
3.4 Premium Industry Trends .....................................................................................................30
3.4.1 Rising healthcare expenditures across the world .........................................................30
3.4.2 Increased outsourcing of clinical research activities ....................................................30
3.4.3 Globalization of clinical trials ........................................................................................30
4 INDUSTRY ANALYSIS......................................................................................................................31
4.1 Supply Chain Analysis............................................................................................................31
4.2 Ecosystem Analysis ...............................................................................................................32
SAMPLE
4
5 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY COMPONENTS...........................33
5.1.1 Global Clinical trial management systems (CTMS) Market Share (%), By Components,2016 & 2022..................................................................................................................................33
5.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022)...........................................................................................................34
5.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents, 2016 & 2022 ...........................................................................................................35
5.2 Software................................................................................................................................36
5.2.1 Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion),By Regions (2014 – 2022)..............................................................................................................36
5.3 Service...................................................................................................................................37
5.3.1 Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), ByRegions (2014 – 2022)...................................................................................................................37
6 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY END-USERS................................38
6.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users,2016 & 2022..................................................................................................................................39
6.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022).......................................................................................................................39
6.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users, 2016 & 2022 .......................................................................................................................40
6.2 Pharmaceutical and Biotechnology Companies ...................................................................41
6.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) inPharmaceutical and Biotechnology, By Regions (2014 – 2022)....................................................41
6.3 Clinical Research Organizations (CROs) ................................................................................41
6.3.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in ClinicalResearch Organizations (CROs), By Regions (2014 – 2022) ..........................................................41
6.4 Medical Device Companies ...................................................................................................42
6.4.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in MedicalDevice Companies, By Regions (2014 – 2022) ..............................................................................42
7 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY DELIVERY MODES......................43
7.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By DeliveryMode, 2016 & 2022 ......................................................................................................................44
7.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode (2014 – 2022) .......................................................................................................44
7.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode, 2016 & 2022 ........................................................................................................45
SAMPLE
5
7.2 Web-Based Delivery Mode ...................................................................................................46
7.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Web-based Delivery Mode, By Regions (2014 – 2022) .........................................................................46
7.3 On-Site Delivery Mode..........................................................................................................47
7.3.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in On-SiteDelivery Mode, By Regions (2014 – 2022) ....................................................................................47
7.4 Cloud-Based Delivery Mode..................................................................................................47
7.4.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Cloud-based Delivery Mode, By Regions (2014 – 2022) .........................................................................47
8 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY REGIONS....................................48
8.1 Segment Share ......................................................................................................................49
8.1.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByRegions (2014 – 2022)...................................................................................................................49
8.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByRegions, 2016 & 2022 ...................................................................................................................50
8.2 North America.......................................................................................................................51
8.2.1 North America Clinical Trial Management Systems (CTMS) Market Share (%), ByCountry, 2016 & 2022...................................................................................................................51
8.2.2 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Country (2014 – 2022) .............................................................................................................52
8.2.3 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Country, 2016 & 2022 ..............................................................................................................52
8.2.3.1 U.S. ............................................................................................................................53
8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................53
8.2.3.2 Rest of North America...............................................................................................53
8.2.3.2.1 Clinical Trial Management Systems (CTMS) Market in Rest of North America,Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................53
8.2.4 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Components (2014 – 2022)......................................................................................................54
8.2.5 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By End-users (2014 – 2022) ..........................................................................................................54
8.2.6 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Delivery Mode (2014 – 2022)...................................................................................................55
8.3 Europe...................................................................................................................................56
SAMPLE
6
8.3.1 Europe Clinical Trial Management Systems (CTMS) Market Share (%), By Country,2016 & 2022..................................................................................................................................56
8.3.2 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry (2014 – 2022) ..................................................................................................................57
8.3.3 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry, 2016 & 2022...................................................................................................................57
8.3.3.1 France........................................................................................................................58
8.3.3.1.1 Clinical Trial Management Systems (CTMS) Market in France, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................58
8.3.3.2 Germany....................................................................................................................58
8.3.3.2.1 Clinical Trial Management Systems (CTMS) Market in Germany, Market Size(US$ billion) and Y-o-Y Growth (%) .......................................................................................58
8.3.3.3 U.K.............................................................................................................................59
8.3.3.3.1 Clinical Trial Management Systems (CTMS) Market in U.K, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................59
8.3.3.4 Rest of Europe...........................................................................................................59
8.3.3.4.1 Clinical Trial Management Systems (CTMS) Market in Rest of Europe, MarketSize (US$ billion) and Y-o-Y Growth (%) ................................................................................59
8.3.4 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022)...........................................................................................................59
8.3.5 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022).......................................................................................................................60
8.3.6 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode (2014 – 2022) .......................................................................................................60
8.4 Asia-Pacific ............................................................................................................................61
8.4.1 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share (%), By Country,2016 & 2022..................................................................................................................................61
8.4.2 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry (2014 – 2022) ..................................................................................................................62
8.4.3 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry, 2016 & 2022...................................................................................................................63
8.4.3.1 China .........................................................................................................................63
8.4.3.1.1 Clinical Trial Management Systems (CTMS) Market in China, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................63
8.4.3.2 India...........................................................................................................................64
SAMPLE
7
8.4.3.2.1 Clinical Trial Management Systems (CTMS) Market in India, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................64
8.4.3.3 Japan .........................................................................................................................64
8.4.3.3.1 Clinical Trial Management Systems (CTMS) Market in Japan, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................64
8.4.3.4 Rest of Asia-Pacific ....................................................................................................64
8.4.3.4.1 Clinical Trial Management Systems (CTMS) Market in Rest of Asia-Pacific,Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................64
8.4.4 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022)...........................................................................................................65
8.4.5 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByEnd-users (2014 – 2022) ...............................................................................................................65
8.4.6 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode (2014 – 2022) .......................................................................................................66
8.5 Rest of the World (RoW).......................................................................................................67
8.5.1 RoW Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016& 2022 67
8.5.2 RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country(2014 – 2022) ................................................................................................................................68
8.5.3 RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country,2016 & 2022..................................................................................................................................68
8.5.3.1 Latin America ............................................................................................................69
8.5.3.1.1 Clinical Trial Management Systems (CTMS) Market in Latin America, MarketSize (US$ billion) and Y-o-Y Growth (%) ................................................................................69
8.5.3.2 Middle East and Africa ..............................................................................................69
8.5.3.2.1 Clinical Trial Management Systems (CTMS) Market in Middle East and Africa,Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................69
8.5.4 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Components (2014 – 2022).........................................................................................70
8.5.5 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$billion), By End-users (2014 – 2022) .............................................................................................70
8.5.6 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Delivery Mode (2014 – 2022)......................................................................................71
9 COMPETITIVE LANDSCAPE ............................................................................................................72
9.1 Market Positioning of Key Players ........................................................................................72
10 KEY MARKET PLAYERS...................................................................................................................73
SAMPLE
8
10.1.1 Medidata Solutions, Inc. ...............................................................................................73
10.1.2 Overview .......................................................................................................................73
10.1.3 Key Strategies................................................................................................................73
10.1.3.1 Focus on Product Innovation ................................................................................73
10.1.3.2 Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities73
10.1.4 Recent Developments...................................................................................................73
10.2 PAREXEL International Corporation. .....................................................................................75
10.2.1 Overview .......................................................................................................................75
10.2.2 Key Strategies................................................................................................................75
10.2.2.1 Strategic Acquisitions and Partnerships to Strengthen Client Base .....................75
10.2.2.2 Innovative Product Development .........................................................................75
10.2.2.3 Market Expansion .................................................................................................75
10.2.3 Recent Developments...................................................................................................75
10.3 Bioclinica. ..............................................................................................................................77
10.3.1 Overview .......................................................................................................................77
10.3.2 Key Strategies................................................................................................................77
10.3.2.1 Strategic Acquisitions, Collaborations and Partnerships ......................................77
10.3.2.2 New Product Development...................................................................................77
10.3.3 Recent Developments...................................................................................................77
10.4 Bio-Optronics, Inc..................................................................................................................79
10.4.1 Overview .......................................................................................................................79
10.4.2 Key Strategies................................................................................................................79
10.4.2.1 Strategic Acquisitions and Collaborations ............................................................79
10.4.3 Recent Developments...................................................................................................79
10.5 ERT Clinical. ...........................................................................................................................80
10.5.1 Overview .......................................................................................................................80
10.5.2 Key Strategies................................................................................................................80
10.5.2.1 Product Development ...........................................................................................80
10.5.2.2 Strategic Market Expansion ..................................................................................80
10.5.2.3 Strategic Acquisitions to Expand their Capabilities...............................................80
SAMPLE
9
10.5.3 Recent Development ....................................................................................................80
10.6 DATATRAK International, Inc. ...............................................................................................82
10.6.1 Overview .......................................................................................................................82
10.6.2 Key Strategies................................................................................................................82
10.6.2.1 Product Innovation ...............................................................................................82
10.6.2.2 Strategic Acquisitions, Collaborations and Partnerships ......................................82
10.6.3 Recent Developments...................................................................................................82
10.7 MedNet Solutions, Inc...........................................................................................................84
10.7.1 Overview .......................................................................................................................84
10.7.2 Key Strategies................................................................................................................84
10.7.2.1 Strategic Acquisitions, Collaborations and Partnerships ......................................84
10.7.3 Recent Developments...................................................................................................84
10.8 Forte Research Systems, Inc. ................................................................................................85
10.8.1 Overview .......................................................................................................................85
10.8.2 Key Strategies................................................................................................................85
10.8.2.1 Strategic Collaborations and Partnerships............................................................85
10.8.3 Recent Developments...................................................................................................85
10.9 Merge Healthcare Incorporated. ..........................................................................................86
10.9.1 Overview .......................................................................................................................86
10.9.2 Key Strategies................................................................................................................86
10.9.2.1 Focus on Strategic Acquisitions, Collaborations and Partnerships .......................86
10.9.3 Recent Developments...................................................................................................86
10.10 Veeva Systems ......................................................................................................................88
10.10.1 Overview ...................................................................................................................88
10.10.2 Key Strategies............................................................................................................88
10.10.2.1 Focus on Market Expansion ..................................................................................88
10.10.2.2 Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities..88
10.10.3 Recent Developments...............................................................................................88
10.11 DSG, Inc. ................................................................................................................................90
10.11.1 Overview ...................................................................................................................90
SAMPLE
10
10.11.2 Key Strategies............................................................................................................90
10.11.2.1 Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities..90
10.11.3 Recent Developments...............................................................................................90
11 SCALAR 360 DEGREE MARKET PERSPECTIVE ................................................................................91
12 APPENDIX ......................................................................................................................................93
12.1 Acronyms ..............................................................................................................................93
12.2 Related Reports.....................................................................................................................94
SAMPLE
11
List of Tables
Table 1. Primary Data .....................................................................................................................17
Table 2. Primary Sources ................................................................................................................17
Table 3. Secondary Data .................................................................................................................17
Table 4. Advantages of Machine Learning-based Forecasts ..........................................................18
Table 5. Years Considered ..............................................................................................................20
Table 6. Global Clinical Trial Management Systems (CTMS) Market Snapshot..............................25
Table 7. Global Clinical Trial Management Systems (CTMS) Market Drivers .................................26
Table 8. Global Clinical Trial Management Systems (CTMS) Market Restraints ............................27
Table 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022) ..................................................................................................................34
Table 10. Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion), ByRegions (2014 – 2022) ..........................................................................................................................36
Table 11. Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), ByRegions (2014 – 2022) ..........................................................................................................................37
Table 12. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users(2014 – 2022) ........................................................................................................................................39
Table 13. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) inPharmaceutical and Biotechnology, By Regions (2014 – 2022)............................................................41
Table 14. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in ClinicalResearch Organizations (CROs), By Regions (2014 – 2022)..................................................................41
Table 15. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in MedicalDevice Companies, By Regions (2014 – 2022) ......................................................................................42
Table 16. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By DeliveryMode (2014 – 2022)..............................................................................................................................44
Table 17. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Web-based Delivery Mode, By Regions (2014 – 2022) .................................................................................46
Table 18. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in On-SiteDelivery Mode, By Regions (2014 – 2022) ............................................................................................47
Table 19. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Cloud-based Delivery Mode, By Regions (2014 – 2022) .................................................................................47
Table 20. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions(2014 – 2022) ........................................................................................................................................49
SAMPLE
12
Table 21. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry (2014 – 2022) ..........................................................................................................................52
Table 22. 8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................................53
Table 23. Clinical Trial Management Systems (CTMS) Market in Rest of North America, Market Size(US$ billion) and Y-o-Y Growth (%) .......................................................................................................53
Table 24. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022) ..................................................................................................................54
Table 25. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByEnd-users (2014 – 2022) .......................................................................................................................54
Table 26. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode (2014 – 2022) ...............................................................................................................55
Table 27. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country(2014 – 2022) ........................................................................................................................................57
Table 28. Clinical Trial Management Systems (CTMS) Market in France, Market Size (US$ billion)and Y-o-Y Growth (%)............................................................................................................................58
Table 29. Clinical Trial Management Systems (CTMS) Market in Germany, Market Size (US$ billion)and Y-o-Y Growth (%)............................................................................................................................58
Table 30. Clinical Trial Management Systems (CTMS) Market in U.K, Market Size (US$ billion) andY-o-Y Growth (%)...................................................................................................................................59
Table 31. Clinical Trial Management Systems (CTMS) Market in Rest of Europe, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................................59
Table 32. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022) ..................................................................................................................59
Table 33. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022)...............................................................................................................................60
Table 34. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By DeliveryMode (2014 – 2022)..............................................................................................................................60
Table 35. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry (2014 – 2022) ..........................................................................................................................62
Table 36. Clinical Trial Management Systems (CTMS) Market in China, Market Size (US$ billion)and Y-o-Y Growth (%)............................................................................................................................63
Table 37. Clinical Trial Management Systems (CTMS) Market in India, Market Size (US$ billion) andY-o-Y Growth (%)...................................................................................................................................64
Table 38. Clinical Trial Management Systems (CTMS) Market in Japan, Market Size (US$ billion)and Y-o-Y Growth (%)............................................................................................................................64
Table 39. Clinical Trial Management Systems (CTMS) Market in Rest of Asia-Pacific, Market Size(US$ billion) and Y-o-Y Growth (%) .......................................................................................................64
SAMPLE
13
Table 40. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents (2014 – 2022) ..................................................................................................................65
Table 41. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022)...............................................................................................................................65
Table 42. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode (2014 – 2022) ...............................................................................................................66
Table 43. RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country(2014 – 2022) ........................................................................................................................................68
Table 44. Clinical Trial Management Systems (CTMS) Market in Latin America, Market Size (US$billion) and Y-o-Y Growth (%)................................................................................................................69
Table 45. Clinical Trial Management Systems (CTMS) Market in Middle East and Africa, MarketSize (US$ billion) and Y-o-Y Growth (%)................................................................................................69
Table 46. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Components (2014 – 2022)..............................................................................................................70
Table 47. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By End-users (2014 – 2022) ..................................................................................................................70
Table 48. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Delivery Mode (2014 – 2022)...........................................................................................................71
Table 49. Clinical Trial Management Systems (CTMS) Market Snapshot .........................................92
Table 50. List of Acronyms................................................................................................................93
SAMPLE
14
List of Figures
Figure 1. Research Methodology .....................................................................................................20
Figure 2. Global Clinical Trial Management Systems (CTMS) Market, By Components ..................21
Figure 3. Global Clinical Trial Management Systems (CTMS) Market, By Delivery Modes .............21
Figure 4. Global Clinical Trial Management Systems (CTMS) Market, By End-Users ......................22
Figure 5. Global Clinical Trial Management Systems (CTMS) Market, By Regions ..........................22
Figure 6. Clinical Trial Management Systems (CTMS) Market – IoT Enabled Supply Chain Analysis31
Figure 7. Clinical Trial Management Systems (CTMS) Market – Functional Process Map...............32
Figure 8. Global Clinical trial management systems (CTMS) Market Share (%), By Components,2016 & 2022..........................................................................................................................................33
Figure 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByComponents, 2016 & 2022 ...................................................................................................................35
Figure 10. Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users,2016 & 2022 39
Figure 11. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users, 2016 & 2022 ...............................................................................................................................40
Figure 12. Global Clinical Trial Management Systems (CTMS) Market Share (%), By DeliveryMode, 2016 & 2022 ..............................................................................................................................44
Figure 13. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByDelivery Mode, 2016 & 2022 ................................................................................................................45
Figure 14. Global Clinical Trial Management Systems (CTMS) Market Share (%), By Regions, 2016and 2022 49
Figure 15. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByRegions, 2016 & 2022 ...........................................................................................................................50
Figure 16. North America Clinical Trial Management Systems (CTMS) Market Share (%), ByCountry, 2016 & 2022...........................................................................................................................51
Figure 17. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),By Country, 2016 & 2022 ......................................................................................................................52
Figure 18. Europe Clinical Trial Management Systems (CTMS) Market Share (%), By Country,2016 & 2022 56
Figure 19. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry, 2016 & 2022...........................................................................................................................57
SAMPLE
15
Figure 20. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share (%), By Country,2016 & 2022 61
Figure 21. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), ByCountry, 2016 & 2022...........................................................................................................................63
Figure 22. RoW Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016& 2022 67
Figure 23. RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country,2016 & 2022 68
Figure 24. Market Positioning of Key Players ................................................................................72
SAMPLE
16
1 MARKET OVERVIEW
1.1 Definitions
There has been an increase in both the cost and complexity of conducting clinical
trials that is in turn threatening the profit quotient of drug candidates and the
economic feasibility of pharmaceutical drug discovery research. Thus, the industry is
actively looking out to limit these costs, as both the governments and payers of
healthcare are inclining towards lowering the cost of care provision and the
manufacturing cost of pharmaceuticals. Furthermore, the development stage of the
drug lifecycle is a potential source of competitive advantage and is being
increasingly viewed by life sciences organizations. These firms are looking forward
to reducing the cycle times that drug candidates take to reach the market. Thus, the
pharmaceutical manufacturers are increasingly outsourcing the management of
clinical trials from third parties, thereby driving growth in the small and medium-sized
companies of the clinical trial management systems (CTMS) market.
The ‘Clinical Trial Management Systems (CTMS) Market – Global Revenue,Trends, Growth, Share, Size and Forecast to 2022' report includes market size
and forecast estimates for the period 2014 to 2022. The scope of this report includes
software and service components of clinically trial management systems, delivery
modes such as web-based, on-site and cloud-based and their end-users such as
pharmaceutical and biotechnology companies, contract research organizations and
medical device companies. The report segments the market based on components,
delivery modes, end-users, and regions. The report includes market size and
forecast estimates for all market segments in the study period. The report has 2015
as the base year, 2014 as the historical year, and 2016 to 2022 as the forecast
period.
1.2 Research MethodologyWe utilize a mix of primary research, secondary research, and machine learning
algorithms to generate comprehensive data about market sizes and revenue
forecasts. Our primary focus on continuous market tracking, rigorous fact-checking,
data-triangulation, and multiple layers of quality control ensures high-quality data that
can be leveraged for actionable research insights.
SAMPLE
17
1.2.1 Primary DataTable 1. Primary Data
Perspective Primary Research
Supply Side Software Developers Vendors
Demand Side End-users Consumers
Structured interviews with industry specialists, VPs, CEOs, directors, technology
consultants were taken in order to collect the key primary data. The primary data is
focused on both the demand and supply sides of the market. Market Engineering
has been carried out from the data and excessive analysis has been done on it.
Primary data is also extensively considered while validating the secondary data.
Table 2. Primary Sources
Report Parameters Primary Sources
Key Industry Participants (KPIs)
Vendors Government Agencies Regulatory Bodies Research & Development Companies Investment Research Companies Business Consulting Service Providers Academic Institutions/Universities Venture Capitalists
1.2.2 Secondary DataTable 3. Secondary Data
Report Parameters Perspective Secondary Research
Market Size, Revenue,Industry Analysis, ValueChain Analysis,Ecosystem Analysis,Premium IndustryTrends, End-users
Supply Side
Company Annual Reports SEC Filings Financial Journals Trade Journals Market Journals Press Releases
SAMPLE
18
Analysis, MarketSegmentation,Geographic Analysis, KeyMarket Players,Competitive Landscape
Directories White Papers Company Websites Magazines
Demand Side Case Studies Customer References
The data from important secondary sources is utilized to obtain industry supply
chains, company profiles, and other key areas such as market drivers, opportunities,
trends from the market perspective. In addition, secondary data is gathered using
paid databases such as Bloomberg, Hoovers, Factiva, and government publishing
sources.
1.2.3 Machine LearningIn addition to assigning weights to all the relevant market parameters, to quantify
their market impact for generating projected market growth rate, we use advanced
machine learning algorithms to collate essential market data. The machine learning
method utilizes algorithms such as regression, correlation, and decision tree, among
others, to derive the desired output.
Table 4. Advantages of Machine Learning-based Forecasts
Perspective Advantages of Machine Learning-based Forecasts
Using Machine Learning for DataForecast
Unlimited Data Highly Detailed Forecasts Profound Knowledge of Demand Broad Applicability Customizable Model Identifies Drivers Analysis - Product, Value Chain, Supply Chain,
Competitor
1.2.4 Research Scope
We have utilized the top-down, bottom-up approach to study the market size,
industry dynamics, key regional markets, and major market trends. The global
market has been estimated by integrating the regional markets, estimating the
market data for the base year 2015, and annual share and revenue forecasts to
2022 in US$.
SAMPLE
21
1.2.6 Currency & PricingThe currency used in the report is the U.S. dollar, with market size indicated in US$
million and US$ billion.
Revenue is obtained from the annual company reports (For all the companies
reporting their revenue in US$)
Revenue is converted as per the annual currency exchange rate for that
particular year (For the companies reporting their revenue in currencies other
than US$)
1.3 Market Segmentation
Figure 2. Global Clinical Trial Management Systems (CTMS) Market, By Components
Clinical Trial Management Systems,By Components
Software Services
Source: Scalar Market Research Analysis
Figure 3. Global Clinical Trial Management Systems (CTMS) Market, By DeliveryModes
Clinical Trial Management Systems,By Delivery Modes
Web-based Cloud-basedOn-premises
Source: Scalar Market Research Analysis
SAMPLE
22
Figure 4. Global Clinical Trial Management Systems (CTMS) Market, By End-Users
Clinical Trial Management System,By End-users
Pharmaceutical &Biotechnology
Companies
Medical DeviceCompanies
Clinical ResearchOrganizations
Source: Scalar Market Research Analysis
Figure 5. Global Clinical Trial Management Systems (CTMS) Market, By Regions
Clinical Trial Management System,By Regions
North America Rest of theWorldEurope Asia Pacific
U.S.
Rest of NorthAmerica
France
Germany
U.K
Rest of Europe
China
India
Japan
Rest of APAC
Latin America
MEA
Source: Scalar Market Research AnalysisSAMPLE
24
2 EXECUTIVE SUMMARYThe objective of this report is to describe the market trends and revenue forecasts
for the Clinical Trial Management Systems (CTMS) market for the next six years.
The report focuses on defining and describing the key influencing factors for the
growth of the market. It also offers an in-depth analysis of the market size (revenue),
market share, major market segments, different geographic regions, key market
players, and premium industry trends.
The report tracks the major market events including product launches, technological
developments, mergers & acquisitions, and the innovative business strategies opted
by key market players. Along with strategically analyzing the key micro-markets, the
report also focuses on industry-specific drivers, restraints, and opportunities in the
Clinical Trial Management Systems (CTMS) market. The scope of this report covers
the Clinical Trial Management Systems (CTMS) market by its major segments, which
include the components, end-users, and the major geographic regions.
The key market players profiled in this report are Medidata Solutions, Inc., BioClinica
Inc., DATATRAK International Inc., Forte Research Systems, Inc., Bio-Optronics,
Inc., PAREXEL International Corporation, Merge Healthcare Incorporated, ERT
Clinical, Veeva Systems, Inc., and MedNet Solutions, Inc.
SAMPLE
25
Table 6. Global Clinical Trial Management Systems (CTMS) Market Snapshot
Source: Scalar Market Research Analysis
Global Clinical Trial Management Systems (CTMS)Market
Market Size (US$ billion)CAGR%
(2016 – 2022)2016 2022
Total 1.32 2.95 14.3
Com
pone
nts
Largest Segment, by Revenue –Software
End-
user
s
Largest Segment, by Revenue –Pharmaceutical and BiotechnologyCompaniesFastest Growing Segment – ContractResearch Organizations
Deliv
ery
Mod
e
Largest Segment, by Revenue – Web-based
Fastest Growing Segment – Cloud-based
Regi
ons
Largest Segment, by Revenue – NorthAmerica
Fastest Growing Segment – Asia-Pacific
Coun
try Largest Segment, by Revenue – U.S.
Fastest Growing Segment – India
SAMPLE
26
3 MARKET DYNAMICS
3.1 Drivers
Table 7. Global Clinical Trial Management Systems (CTMS) Market Drivers
Drivers 2014 – 16 2017 – 19 2020 – 22
Increasing research and development expense in clinicalresearch industries
The research and development (R&D) wing of clinical researchindustry has remained capital intensive owing to its longdevelopment cycles. As the clinical industry is a research-intensive industry, majority of its activities are driven by theR&D funding.
According to the Industrial Research Institute, the NationalInstitutes of Health (NIH) possesses the second largest federalR&D budget of around $31.3 billion in 2016. The NationalCancer Institute (NCI) possesses a research budget of over $5billion in 2016. Also, the emerging countries such as China andIndia are providing robust funds in order to boost their clinicalresearch industry.
●
◕◑
Source: Scalar Market Research Analysis
Note: ● Very High Impact,◕ High Impact,◑ Medium Impact,◔ Low ImpactSAM
PLE
27
3.2 Restraints
Table 8. Global Clinical Trial Management Systems (CTMS) Market Restraints
Restraints 2014 – 16 2017 – 19 2020 – 22
Lack of efficient and skilled professionals to operate on high-tech CTMS solutions
There is a lack of qualified healthcare professionals owing to theunder investment in healthcare sector. Also, there has been anincrease in the emigration of healthcare personnel from theirnative states to high income countries. The health workers arediscouraged owing to the poor working conditions, obsoleteequipment, lack of professional development opportunities, andthe absence of security measures
●
●Source: Scalar Market Research Analysis
Note: ● Very High Impact,◕ High Impact,◑ Medium Impact,◔ Low Impact
SAMPLE
32
4.2 Ecosystem AnalysisFigure 7. Clinical Trial Management Systems (CTMS) Market – Functional Process
Map
Study DesignProtocol
Developmentand Scientific
Feasibility
Study Idea
StartService
ProviderOperationalReadiness
Study Design Phase(Language Must Harmonize / Operational
Activities Must Synchronize)
BudgetDevelopment
IRBApproval
Clinical TrialAgreement
and/or Award
CompleteOperationalReadiness
StudyCompletion
Study Close Out Phase
Study Close PaymentReconciliation
Patient Management Phase
Service Provider /Charge Generated
Patient Screening/ Enrolment /Registration
ScheduleServices
Source: Scalar Market Research Analysis
SAMPLE
33
5 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,BY COMPONENTS
The global clinical trial management systems (CTMS) market is expected to be
valued at US$ XX billion in 2016. This market is expected to grow at a CAGR of
XX% in the forecast period and reach US$ XX billion by 2022. The global clinical trial
management systems (CTMS) market is bifurcated by components into software and
service. The software is the largest market segment comprising of XX% share of the
global clinical trial management systems (CTMS) market in 2016. Also, this market
segment is expected to grow at the highest rate in the forecast period. The share of
this market segment is expected to grow from XX% in 2016 to XX% in the 2022.
5.1.1 Global Clinical trial management systems (CTMS) Market Share (%), ByComponents, 2016 & 2022
Figure 8. Global Clinical trial management systems (CTMS) Market Share (%), ByComponents, 2016 & 2022
72.5%
21.3%
6.1%
2016
65.3%
26.2%
8.5%
2022
Hardware
Software
Service
Source: Scalar Market Research Analysis
The software market component segment dominated the clinical trial management
systems (CTMS) market as it accounted for XX% of the market share in terms of
revenue in 2015. This segment is expected to be valued at US$ XX billion in 2022.
Factors such as high popularity of cost-effective drugs in the biopharmaceutical
industry, rising rate of adoption of CTMS owing to its various advantages and
SAMPLE
34
increasing number of clinical trials is analyzed to propel the demand for software
components during the forecast period. Also, the emergence of innovative drugs and
intense competition among various pharmaceutical firms to complete the clinical
trials and benefit from first to market strategy is expected to raise the demand for
CTMS.
Also, the software components segment is expected to be the fastest-growing
segment during the forecast period. This segment is expected to grow at a CAGR of
XX% between 2016 and 2022. Increasing government spending across the
emerging economies of Asia-Pacific, Middle East & Africa, and Latin America, rising
rate of adoption of CTMS solutions, enhanced product portfolio and increasing R&D
expenditure of clinical research industry across the globe is analyzed to boost the
software segment during the forecast period.
5.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Components (2014 – 2022)
Table 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Components (2014 – 2022)
Components 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
Software
Service
Total
Source: Scalar Market Research AnalysisSAM
PLE
35
5.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Components, 2016 & 2022
Figure 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Components, 2016 & 2022
0.97
0.35
2.20
0.75
Software Service
US$ b
illion
2016 2022
Source: Scalar Market Research Analysis
SAMPLE
36
5.2 Software
5.2.1 Global Clinical Trial Management Systems (CTMS) Software Market Size(US$ billion), By Regions (2014 – 2022)
Table 10. Global Clinical Trial Management Systems (CTMS) Software Market Size(US$ billion), By Regions (2014 – 2022)
Regions 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
NorthAmerica
Europe
Asia-Pacific
Rest of theWorld
Total
Source: Scalar Market Research Analysis
SAMPLE
37
5.3 Service
5.3.1 Global Clinical Trial Management Systems (CTMS) Service Market Size(US$ billion), By Regions (2014 – 2022)
Table 11. Global Clinical Trial Management Systems (CTMS) Service Market Size(US$ billion), By Regions (2014 – 2022)
Regions 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
NorthAmerica
Europe
Asia-Pacific
Rest of theWorld
Total
Source: Scalar Market Research Analysis
SAMPLE
38
6 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,BY END-USERS
The global Clinical trial management systems (CTMS) market is bifurcated by end-
users into pharmaceutical and biotechnology companies, clinical research
organizations, and medical device companies. The pharmaceutical and
biotechnology companies’ end-user segment dominated the clinical trial
management systems (CTMS) market in 2015, as it accounted for XX% of the
market share in terms of revenue. This segment is expected to be valued at US$ XX
billion in 2022. The coupling of CTMS along with hospital information system (HIS)
provides accurate and time-saving documentation during the process of drug
formulation and thereby, simplifies the clinical trials. The major factors propelling the
growth of this market include vast research activities and innovation. There has been
an increase in the research and development funds over the years and introduction
of government-based clinical studies are expected to further spur the growth.
On the other hand, clinical research organizations end-user segment is expected to
be the fastest-growing segment during the forecast period. This segment is analyzed
to grow at a CAGR of XX% between 2016 and 2022. Majority of the
biopharmaceutical companies have become increasingly dependent on the contract
research organizations (CRO) sector in order to provide research services across
their research and development operations.SAMPLE
39
6.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), ByEnd-users, 2016 & 2022
Figure 10. Global Clinical Trial Management Systems (CTMS) Market Share (%), ByEnd-users, 2016 & 2022
7.5%
24.6%
5.4%
16.6%3.0%5.3%
18.4%
8.4%1.2%
2.3%7.3%
2016
9.1%
22.8%
4.4%
20.2%2.3%
4.8%
15.9%
8.1%1.2%
2.4%8.7%
2022 Banking & Finance
Commercial
Education
Government
Healthcare
Manufacturing &IndustrialResidential
Retail
Sports & Leisure
Transportation
Utilities & Energy
Source: Scalar Market Research Analysis
6.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By End-users (2014 – 2022)
Table 12. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By End-users (2014 – 2022)
End-users 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
PharmaceuticalandBiotechnologycompaniesClinicalResearchOrganizationsMedical DeviceCompanies
Total
Source: Scalar Market Research Analysis
SAMPLE
40
6.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By End-users, 2016 & 2022
Figure 11. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By End-users, 2016 & 2022
4.60
15.13
3.33
10.18
1.833.24
11.33
5.172.22
10.09
4.48
11.98
29.95
5.73
26.47
3.07 6.35
20.89
10.68
3.04
29.24
11.38
US$
billio
n
2016 2022
Source: Scalar Market Research Analysis
SAMPLE
43
7 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,BY DELIVERY MODES
The global clinical trial management systems (CTMS) market is bifurcated by
delivery modes into web-based, on-premise, and cloud-based mode. The web-
based delivery mode segment dominated the clinical trial management systems
(CTMS) market in 2015, as it accounted for XX% of the market share in terms of
revenue. This segment is expected to be valued at US$ XX billion in 2022. Factors
such as enhancement of the clinical trial efficiency owing to the optimized process;
centralized database; better site performance by augmented investigator
relationships; reduced workload for research coordinators; efficiency in budgeting
and financial management; and automated data processing and report generation
are propelling the market for web-based delivery mode market.
On the other hand, cloud-based delivery mode segment is expected to be the
fastest-growing segment during the forecast period. The segment is analyzed to
grow at a CAGR of XX% between 2016 and 2022. The cloud-based solutions are
gaining huge popularity over the recent years. This technology leads to efficiency
and cost-effectiveness in clinical data management, and it works well for both
pharmaceutical companies as well as their CROs. The cloud-based infrastructure
helps to have seamless experience as it streamlines data thereby improving its
quality. SAMPLE
44
7.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), ByDelivery Mode, 2016 & 2022
Figure 12. Global Clinical Trial Management Systems (CTMS) Market Share (%), ByDelivery Mode, 2016 & 2022
56.0%
23.7%
20.3%
2016
55.4%
22.5%
22.2%
2022
Web-based
On-premises
Cloud-based
Source: Scalar Market Research Analysis
7.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Delivery Mode (2014 – 2022)
Table 16. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Delivery Mode (2014 – 2022)
End-users 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
Web-based
On-premises
Cloud-based
Total
Source: Scalar Market Research Analysis
SAMPLE
45
7.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Delivery Mode, 2016 & 2022
Figure 13. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Delivery Mode, 2016 & 2022
0.74
0.310.27
1.63
0.66 0.65
Web-based On-premises Cloud-based
US$ b
illion
2016 2022
Source: Scalar Market Research Analysis
SAMPLE
46
7.2 Web-Based Delivery Mode
7.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion) in Web-based Delivery Mode, By Regions (2014 – 2022)
Table 17. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion)in Web-based Delivery Mode, By Regions (2014 – 2022)
Regions 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
NorthAmerica
Europe
Asia-Pacific
Rest of theWorld
Total
Source: Scalar Market Research Analysis
SAMPLE
48
8 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,BY REGIONS
The global clinical trial management systems (CTMS) market is segmented into
regional segments of North America, Europe, Asia-Pacific (APAC), Middle East &
Africa (MEA), and Latin America (LATAM). The clinical trial management systems
(CTMS) market is a highly-fragmented market with numerous budding small-scale
companies.
The North American region is a market leader in clinical trial management systems
(CTMS) market and is estimated to continue its dominance over the forecast period
owing to increasing number of clinical trials and growing rate of adoption of
technology advanced CTMS in this region. As per the National Institute of Health
(NIH), in the year 2011, over 56,981 clinical trials were carried out in the U.S. alone.
Also, there is the presence and development of advanced IT infrastructure within this
region that further boosts the market growth. Furthermore, the presence of by-laws
such as Health Insurance Portability and Accountability Act (HIPPA) that help in the
prevention of misuse & fraud, and entry of various new players is expected to
positively impact the market growth
However, the Asia-Pacific is a fastest growing market and is projected to grow at a
rate of XX% during the forecast period due to the presence of large patient base,
presence of favorable regulatory guidelines, cost-effective clinical trials when
compared to developed nations, and the rise of vast number of contract research
organizations (CROs) in this region. Also, there has been a rise in the number of
outsourced clinical trials in the Asia-Pacific region owing to the low-cost clinical trials
facility that is set to further propel the growth of this market. The market is driven by
other factors such as expanding enterprises, organizational pressures to limit costs,
regulatory compliance, new technologies affecting a customer’s security operations,
and security threats.
SAMPLE
49
8.1 Segment ShareFigure 14. Global Clinical Trial Management Systems (CTMS) Market Share (%), By
Regions, 2016 and 2022
34.2%
30.5%
21.7%
13.6%
2016
31.1%
27.1%
27.2%
14.6%
2022NorthAmerica
Europe
Asia-Pacific
RoW
Source: Scalar Market Research Analysis
North America is analyzed to be the largest regional segment as it is valued at US$
XX billion in 2015. However, Asia-Pacific is expected to be the fastest-growing
regional segment in the forecast period. This segment is expected to grow at a
CAGR of XX% between 2016 and 2022 to account for US$ XX billion in 2022.
8.1.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Regions (2014 – 2022)
Table 20. Global Clinical Trial Management Systems (CTMS) Market Size (US$billion), By Regions (2014 – 2022)
Regions 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
NorthAmerica
Europe
Asia-Pacific
Rest of theWorld
Total
Source: Scalar Market Research Analysis
SAMPLE
51
8.2 North America
North America dominated the global clinical trial management systems (CTMS)
market as it accounted for over XX% of the global market share in terms of revenue
in 2015. The U.S. accounts for over XX% of North America’s market share in 2015.
The clinical trial management systems software market in the U.S. is the largest
market globally in terms of revenues. This is owing to the presence of advanced and
integrated IT infrastructure in this region.
8.2.1 North America Clinical Trial Management Systems (CTMS) Market Share(%), By Country, 2016 & 2022
Figure 16. North America Clinical Trial Management Systems (CTMS) Market Share(%), By Country, 2016 & 2022
81.7%
18.3%
2016
80.1%
19.9%
2022
U.S.
Rest of NorthAmerica
Source: Scalar Market Research Analysis
The U.S. clinical trial management systems (CTMS) market is analyzed to be driven
by rising number of clinical trials and increasing pharmaceutical research and
development leading to development of innovative drugs. Majority of the clinical trials
in the U.S. are funded by the National Institute of Health (NIH), academic groups,
other government agencies, and voluntary health organizations. Thus, owing to
increased governmental support and funding for the clinical research, the U.S. has
become a preferred location for conducting clinical trials. The region is analyzed to
grow at a CAGR of XX% during the forecast period.
SAMPLE
52
8.2.2 North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Country (2014 – 2022)
Table 21. North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Country (2014 – 2022)
Country 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
U.S.
Rest ofNorthAmerica
Total
Source: Scalar Market Research Analysis
8.2.3 North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Country, 2016 & 2022
Figure 17. North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Country, 2016 & 2022
0.37
0.08
0.74
0.18
U.S. Rest of North America
US$ b
illion
2016 2022
Source: Scalar Market Research Analysis
SAMPLE
53
8.2.3.1 U.S.
8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$billion) and Y-o-Y Growth (%)
Table 22. 8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., MarketSize (US$ billion) and Y-o-Y Growth (%)
Year 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
Market Size
Source: Scalar Market Research Analysis
8.2.3.2 Rest of North America
8.2.3.2.1 Clinical Trial Management Systems (CTMS) Market in Rest of North America,Market Size (US$ billion) and Y-o-Y Growth (%)
Table 23. Clinical Trial Management Systems (CTMS) Market in Rest of NorthAmerica, Market Size (US$ billion) and Y-o-Y Growth (%)
Year 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
Market Size
Source: Scalar Market Research AnalysisSAMPLE
54
8.2.4 North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Components (2014 – 2022)
Table 24. North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By Components (2014 – 2022)
Components 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
Software
Service
Total
Source: Scalar Market Research Analysis
8.2.5 North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By End-users (2014 – 2022)
Table 25. North America Clinical Trial Management Systems (CTMS) Market Size(US$ billion), By End-users (2014 – 2022)
End-users 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%(2016 – 2022)
PharmaceuticalandBiotechnologycompaniesClinicalResearchOrganizationsMedical DeviceCompanies
Total
Source: Scalar Market Research Analysis
SAMPLE
72
9 COMPETITIVE LANDSCAPE
9.1 Market Positioning of Key Players
The global clinical trial market systems (CTMS) market is dominated by Oracle
Corporation and PAREXEL International Corporation. These vendors have
historically commanded the highest share of the CTMS market. These vendors
provide durable and comprehensive enterprise-class solutions. However, over the
recent years, Medidata has brought various innovative approaches and solutions to
the CTMS market. The approach adopted by Medidata includes cloud-based,
modularized platform approach. This enables customers to procure accurately their
requirements with novel integration with cloud-based EDC solution. The other major
vendors are also following Medidata by providing innovative incorporation with their
private cloud deployment and EDC solutions options.
Figure 24. Market Positioning of Key Players
Oracle Corporation PAREXEL International CorporationMedidata Solutions Merge Healthcare IncorporatedBio-Optronics, Inc ERT Clinical.DATATRAK International, Inc Forte Research Systems, Inc.DSG, Inc. Veeva Systems
Medium High
Med
ium
High
Low
Low
Geog
raph
icRe
ach
Product
Source: Annual Reports, Investor Presentations ,Primary Interviews and Scalar Market Research Analysis
NOTE: Horizontal axis: Product Diversification, Vertical axis: Geographic Reach, Size of the Bubble: MarketDevelopments
SAMPLE
93
12 APPENDIX
12.1 Acronyms
Table 50. List of Acronyms
Acronym Expansion
APAC Asia-Pacific
ACaaS Access Control as a Service
CAGR Compound Annual Growth Rate
CCTV Closed-circuit Television
DIY Do it Yourself
LATAM Latin America
PSAP Public Safety Answering Point
PSIM Clinical Trial Management Systems (CTMS) Information Management
RFID Radio-frequency Identification
RoW Rest of the World
VSaaS Video Surveillance as a Service
Y-o-Y Year on YearSource: Scalar Market Research Analysis
SAMPLE
94
12.2 Related Reports
Population Health Management Market, by Delivery Mode (Cloud-based,
On-Premise, Web-based), Component (Services, Software), End-User
(Government Bodies, Healthcare Providers, Healthcare Payers, Employer
Group) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
Digital Health Market, by Services (Tele-Training, Tele-Monitoring, Tele-
Education, Tele-Consultation), Technology (Telemedicine, Digitized Health
Systems), Health Monitoring Wearable Devices (Sleep Sensors, Heart Rate
Monitors, Activity Monitors, Continuous Glucose Monitors, Smart Watches,
Drug Delivery Devices, Wearable Patches) - Global Revenue, Trends,
Growth, Share, Size and Forecast to 2022
SAMPLE
